Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

18.7K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

3.8K
3.8K
Resistivity01:22

Resistivity

4.4K
When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.4K
Resistance01:19

Resistance

5.7K
When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
5.7K
Frequency-dependent Selection01:21

Frequency-dependent Selection

23.1K
When the fitness of a trait is influenced by how common it is (i.e., its frequency) relative to different traits within a population, this is referred to as frequency-dependent selection. Frequency-dependent selection may occur between species or within a single species. This type of selection can either be positive—with more common phenotypes having higher fitness—or negative, with rarer phenotypes conferring increased fitness.
23.1K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic rescue of pathogenic asparaginyl-tRNA synthetase alleles.

Molecular therapy. Nucleic acids·2026
Same author

Histidine Supplementation Stabilizes Hearing and Vision and Improves Growth in HARS1-Related Autosomal Recessive Disorder Associated With Usher-Like Symptoms.

American journal of medical genetics. Part A·2026
Same author

Long-Read Haplotype Phasing Resolves Allelic Configuration as a Missing Layer of Precision Oncology.

medRxiv : the preprint server for health sciences·2026
Same author

Sequencing PARP inhibitors in breast cancer: lessons learned and emerging insights.

NPJ breast cancer·2026
Same author

Mistranslation from an endogenous tRNA variant in human pan-genome cell lines.

Nucleic acids research·2026
Same author

Inhibition of the integrated stress response rescues a histidyl-tRNA synthetase variant associated with Charcot-Marie-Tooth disease.

NAR molecular medicine·2026
Same journal

A temporal phospho-acetylome atlas of human myogenesis identifies coordinated post-translational regulation.

Molecular & cellular proteomics : MCP·2026
Same journal

Temporal proteomic characterization of SARS-CoV-2 infected mouse lungs.

Molecular & cellular proteomics : MCP·2026
Same journal

Platelet proteome links metabolism to reactivity in Essential Thrombocythemia.

Molecular & cellular proteomics : MCP·2026
Same journal

Genetic rescue of disrupted synaptic protein interaction network dynamics following SYNGAP1 reactivation.

Molecular & cellular proteomics : MCP·2026
Same journal

ASAP-ID: Proximity labelling with small tags.

Molecular & cellular proteomics : MCP·2026
Same journal

Proteome profiling reveals NQO2 activity contributing to proteasome inhibitor resistance in multiple myeloma cell lines.

Molecular & cellular proteomics : MCP·2026
See all related articles

Related Experiment Video

Updated: Jan 23, 2026

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling in Arabidopsis
05:47

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling in Arabidopsis

Published on: June 25, 2020

5.7K

LIN28A-Dependent Kinome and Phosphoproteome Reprogramming Promotes Imatinib Resistance.

Owen F J Hovey1, Mallory I Frederick1, Quan M Quach1

  • 1Department of Biochemistry, Western University, London, Ontario, Canada.

Molecular & Cellular Proteomics : MCP
|January 21, 2026
PubMed
Summary
This summary is machine-generated.

LIN28A, a protein overexpressed in imatinib-resistant chronic myeloid leukemia (CML), drives resistance by coordinating kinase networks. Targeting LIN28A or its downstream kinases, like PKC, can overcome resistance to BCR-ABL tyrosine kinase inhibitors (TKIs).

Keywords:
AKT/mTOR signallingLIN28Achronic myeloid leukemiaimatinib resistancekinome reprograming

More Related Videos

Direct Reprogramming of Mouse Fibroblasts into Melanocytes
09:38

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

2.5K
Author Spotlight: Advancing EVtrap for High-Throughput Proteomics in Disease Biomarker Discovery
09:28

Author Spotlight: Advancing EVtrap for High-Throughput Proteomics in Disease Biomarker Discovery

Published on: October 27, 2023

3.6K

Related Experiment Videos

Last Updated: Jan 23, 2026

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling in Arabidopsis
05:47

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling in Arabidopsis

Published on: June 25, 2020

5.7K
Direct Reprogramming of Mouse Fibroblasts into Melanocytes
09:38

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

2.5K
Author Spotlight: Advancing EVtrap for High-Throughput Proteomics in Disease Biomarker Discovery
09:28

Author Spotlight: Advancing EVtrap for High-Throughput Proteomics in Disease Biomarker Discovery

Published on: October 27, 2023

3.6K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Resistance to BCR-ABL tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) is a significant clinical challenge.
  • Mechanisms of TKI resistance include BCR-ABL kinase domain mutations, gene amplification, and kinase-independent pathways.
  • Understanding novel resistance mediators is crucial for developing effective CML therapies.

Purpose of the Study:

  • To investigate the proteomic and phosphoproteomic changes associated with imatinib resistance in CML.
  • To identify novel molecular targets that mediate resistance to BCR-ABL TKIs.
  • To explore therapeutic strategies for overcoming TKI resistance in CML.

Main Methods:

  • Quantitative mass spectrometry was used to compare the proteome and phosphoproteome of imatinib-sensitive (K562) and imatinib-resistant (ImR) CML cells.
  • RNA interference (shRNA) was employed to deplete LIN28A expression.
  • Ectopic expression of LIN28A was performed in parental K562 cells.
  • Pharmacological inhibitors targeting LIN28A-dependent kinases were utilized.

Main Results:

  • LIN28A was identified as a critical mediator of imatinib resistance, significantly overexpressed and hyperphosphorylated in ImR cells.
  • Depletion of LIN28A restored imatinib sensitivity, while its ectopic expression induced resistance.
  • LIN28A coordinates a kinase-substrate network regulating proliferation, survival, and metabolism, driving resistance.
  • Pharmacological inhibition of LIN28A-dependent kinases (PKC, AKT, SGK1, RPS6K) suppressed ImR cell proliferation.
  • Midostaurin, a PKC/FLT3 inhibitor, re-sensitized ImR cells to imatinib.

Conclusions:

  • LIN28A is a key driver of imatinib resistance in CML, acting through extensive kinase signaling networks.
  • Targeting LIN28A and its downstream effectors, particularly protein kinase C (PKC), represents a promising strategy to overcome resistance to BCR-ABL TKIs.
  • Midostaurin shows potential in combination therapy to re-sensitize CML cells to imatinib and next-generation TKIs.